NCT04553926Completed
'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
Lynparza Tablet (Olaparib) Regulatory Post-Marketing Surveillance
Source: ClinicalTrials.gov · Last updated 23 Jul 2026
Brief summary (registry, in English)
The objectives of this study are to assess safety and effectiveness of Lynparza tablet (olaparib, hereinafter "the study drug") in a real world setting in patients who are prescribed with the study drug according to the approved indications in South Korea
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 661 (actual)
- First submitted
- 10 Sept 2020
- Start date
- 1 Feb 2021
- Primary completion date
- 11 Jul 2025
- Lead sponsor
- AstraZeneca
- Diseases
- Prostate cancer, Pancreatic cancer, Ovarian cancer
- NCT number
- NCT04553926
What you commit to
- Study type: Observational
- Participants enrolled: 661
- From 1 Feb 2021 to the primary completion date, 11 Jul 2025
- 18 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior exposure to any Polyadenosine 5'diphosphoribose polymerase (PARP) inhibitors, including the study drug
Other illness
- History of hypersensitivity to excipients of the study drug or to drugs with a similar chemical structure or class to the study drug
Other
- Pregnant and/or breast feeding
- Current participation in any interventional trial
- Other off-label indications according to the approved label
Who the study is looking for
- Eligible for the study drug treatment according to the approved label in South Korea
- Provision of signed and dated written informed consent by the patient or legally acceptable representative
Age in the registry: 19 years to 150 years · Sex: All · Does not accept healthy volunteers
Sites (18)
Sites in registry order. Save your city in your profile to sort them by distance.
This page is information, not medical advice. Discuss any trial with your doctor.